TRML - Tourmaline Bio, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$48.50
DETAILS
HIGH:
$50.00
LOW:
$47.50
MEDIAN:
$48.00
CONSENSUS:
$48.50
UPSIDE:
1.08%
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | ||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.6 | 0.4 | 0.4 |
| Gross Profit | (0.0) | (0.0) | (0.0) | (0.6) | (0.4) | (0.4) |
| Operating Expenses | ||||||
| R&D Expenses | 67.0 | 32.4 | 17.5 | 0.0 | 15.3 | 13.4 |
| SG&A Expenses | 22.7 | 13.0 | 2.2 | 0.0 | 7.0 | 4.6 |
| Other Expenses | 0 | 0 | 0 | 46.9 | 0 | 0 |
| Operating Expenses | 89.7 | 45.4 | 19.7 | 46.9 | 22.2 | 18.0 |
| Operating Income | ||||||
| Operating Income | (89.7) | (45.4) | (19.7) | (47.5) | (22.7) | (18.4) |
| Interest Expense | 0 | 0 | 0 | 0.3 | 0.0 | 0 |
| Interest Income | 16.5 | 3.3 | 0 | 0 | 0 | 0.2 |
| Profitability | ||||||
| EBITDA | (89.7) | (42.1) | (19.7) | (46.9) | (22.2) | (17.8) |
| EBIT | (73.2) | (42.1) | (19.7) | (47.5) | (22.7) | (18.2) |
| Income Before Tax | (73.2) | (42.1) | (19.7) | (47.8) | (22.7) | (18.2) |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (73.2) | (42.1) | (19.7) | (0.0) | (22.7) | (18.2) |
| Per Share Data | ||||||
| EPS (Basic) | -2.89 | -8.87 | -0.97 | -0.00 | -33.97 | -4.39 |
| EPS (Diluted) | -2.89 | -8.87 | -0.97 | -0.00 | -33.97 | -4.39 |
| Shares Outstanding | 25.3 | 4.7 | 20.3 | 10.9 | 0.7 | 4.1 |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Current Assets | ||||||
| Cash & Cash Equivalents | 30.5 | 140.7 | 8.3 | 18.6 | 17.6 | 39.0 |
| Short-Term Investments | 227.8 | 62.2 | 0 | 225.4 | 131.9 | 0 |
| Net Receivables | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 10.5 | 5.9 | 0 | 0.6 | 0.5 | 0.0 |
| Total Current Assets | 268.8 | 208.9 | 8.3 | 246.5 | 150.8 | 40.8 |
| Non-Current Assets | ||||||
| Property, Plant & Equipment | 0.3 | 0.4 | 0.6 | 4.8 | 2.0 | 1.1 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 36.6 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 3.3 | 1.0 | 0.2 | 0.1 | 0.0 | 0.0 |
| Total Non-Current Assets | 40.2 | 1.4 | 0.8 | 4.9 | 2.0 | 1.1 |
| Total Assets | 309.0 | 210.3 | 9.1 | 251.4 | 152.8 | 41.9 |
| Current Liabilities | ||||||
| Account Payables | 3.6 | 1.1 | 0.4 | 2.6 | 0.8 | 0 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 3.8 | 2.0 | 0.4 | 2.1 | 1.2 | 2.3 |
| Total Current Liabilities | 8.9 | 5.0 | 1.4 | 8.0 | 3.4 | 2.3 |
| Non-Current Liabilities | ||||||
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0.0 | 0.1 | 27.1 | 0.6 | 1.4 | 0.1 |
| Total Non-Current Liabilities | 0.0 | 0.3 | 27.5 | 0.6 | 1.4 | 0.1 |
| Total Liabilities | 8.9 | 5.3 | 28.8 | 8.6 | 4.8 | 2.4 |
| Stockholders' Equity | ||||||
| Common Stock | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (135.3) | (62.1) | (19.9) | (90.8) | (43.0) | (20.3) |
| Accumulated Other Comprehensive Income | 0.3 | 0.1 | 0 | (0.1) | (0.0) | (0.0) |
| Total Stockholders' Equity | 300.1 | 205.0 | (19.7) | 242.8 | 148.0 | 39.6 |
| Total Liabilities & Equity | 309.0 | 210.3 | 9.1 | 251.4 | 152.8 | 41.9 |
| Debt Metrics | ||||||
| Total Debt | 0.2 | 0.4 | 0.5 | 0 | 0 | 0 |
| Net Debt | (30.3) | (140.3) | (7.8) | (18.6) | (17.6) | (39.0) |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | (73.2) | (42.1) | (19.7) | (47.8) | (22.7) | (18.2) |
| Depreciation & Amortization | 0.0 | 0.0 | 0.0 | 0.6 | 0.4 | 0.4 |
| Stock-Based Compensation | 6.6 | 5.8 | 0.2 | 0 | 0 | 0 |
| Change in Working Capital | (3.2) | (0.2) | 0.9 | 2.3 | 1.6 | (0.1) |
| Other Non-Cash Items | (7.5) | 8.4 | 12.1 | 4.9 | 1.4 | 0.2 |
| Operating Cash Flow | (77.3) | (28.1) | (6.5) | (40.0) | (19.2) | (17.7) |
| Investing Activities | ||||||
| Capital Expenditure | (0.0) | (0.1) | (5.1) | (2.4) | (1.3) | (0.6) |
| Acquisitions | 0 | 0 | (5) | 0 | 0 | 0 |
| Purchases of Investments | (366.1) | (16.6) | 0 | (275.9) | (158.2) | 0 |
| Sales/Maturities of Investments | 171.8 | 20.5 | 0 | 181.9 | 26.2 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | (0.0) | 0 |
| Investing Cash Flow | (194.3) | 3.8 | (5.1) | (96.4) | (133.3) | (0.6) |
| Financing Activities | ||||||
| Net Debt Issuance | 0 | 0 | (0.1) | 0 | 0 | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (0.0) | (5.6) | 0 | (0.3) | 0 | 0 |
| Financing Cash Flow | 161.3 | 156.7 | 19.9 | 137.4 | 131.1 | 36.2 |
| Cash Position | ||||||
| Net Change in Cash | (110.2) | 132.5 | 8.3 | 1.0 | (21.4) | 18.0 |
| Cash at Beginning | 141.0 | 8.5 | 0.1 | 17.6 | 39.0 | 21.0 |
| Cash at End | 30.7 | 141.0 | 8.5 | 18.6 | 17.6 | 39.0 |
| Free Cash Flow | (77.3) | (28.1) | (11.5) | (42.4) | (20.5) | (18.2) |
| Key Metrics | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | (0.0) | (0.0) | (0.0) | (0.6) | (0.4) | (0.4) |
| Operating Income | (89.7) | (45.4) | (19.7) | (47.5) | (22.7) | (18.4) |
| Net Income | (73.2) | (42.1) | (19.7) | (0.0) | (22.7) | (18.2) |
| EPS (Diluted) | -2.89 | -8.87 | -0.97 | -0.00 | -33.97 | -4.39 |
| Balance Sheet | ||||||
| Cash & Equivalents | 30.5 | 140.7 | 8.3 | 18.6 | 17.6 | 39.0 |
| Total Assets | 309.0 | 210.3 | 9.1 | 251.4 | 152.8 | 41.9 |
| Total Debt | 0.2 | 0.4 | 0.5 | 0 | 0 | 0 |
| Stockholders' Equity | 300.1 | 205.0 | (19.7) | 242.8 | 148.0 | 39.6 |
| Cash Flow | ||||||
| Operating Cash Flow | (77.3) | (28.1) | (6.5) | (40.0) | (19.2) | (17.7) |
| Capital Expenditure | (0.0) | (0.1) | (5.1) | (2.4) | (1.3) | (0.6) |
| Free Cash Flow | (77.3) | (28.1) | (11.5) | (42.4) | (20.5) | (18.2) |